A fully funded Ph.D. position is available in the laboratory of Dr. Dmitry Kretov at the Centre de recherche du CHU de Québec – Université Laval in Québec City, Canada, starting in Fall 2025.

Our young lab, launched in January 2025, investigates how RNA-binding proteins (RBPs) and microRNAs regulate gene expression during early embryonic development and cancer progression. This position is part of an NSERC-funded project titled "Development of an in vivo high-throughput screening platform to decipher post-transcriptional regulatory networks," which builds on our newly developed method, RBPscan, a quantitative tool for measuring RNA–protein interactions in vivo (Kretov et al., bioRxiv, 2025).

The selected Ph.D. candidate will apply and further develop this technique to decipher the binding specificities of RBPs involved in the assembly of RNA granules, using diverse biological models such as early zebrafish embryos, cancer cell lines, and induced pluripotent stem cells (iPSCs).

As a newly established lab, we offer close mentorship, a collaborative research culture, and a strong commitment to scientific and professional development. Our group is part of the dynamic Oncology Axis, based in a brand-new, state-of-the-art research center located in the beautiful and historic city of Québec, Canada.

We are looking for a highly motivated candidate with a Master’s degree in molecular biology, biochemistry, or a related field. Prior experience with wet-lab molecular biology techniques is required. The ideal candidate should be enthusiastic about learning new experimental approaches and exploring the frontiers of post-transcriptional gene regulation.

To apply, please send the following documents to [email protected]:

• Your curriculum vitae (CV).
• A motivation letter outlining your interest in the position.
• Contact information for at least three references.